Literature DB >> 16180484

Benign prostatic hyperplasia: cost and effectiveness of three alternative surgical treatment methods used in a Turkish hospital.

Ismail Agirbas1, Mehtap Tatar, Adnan Kisa.   

Abstract

The purpose of this study was to compare three alternative surgical therapies for Benign prostatic hyperplasia (BPH) in terms of their cost and effectiveness in a general hospital setting in Turkey. BPH is an important potential burden on health care resources in developing countries like Turkey, not only because of the increasing incidence of the disease, but also because of the differences in cost and effectiveness that exist among the various available treatment technologies. In this study, three alternative surgical treatments for BPH, namely open prostatectomy, transurethral resection of the prostate (TURP), and laser prostatectomy were compared in terms of their cost and effectiveness. Effectiveness was measured through the use of the International Prostate Symptom Score (IPSS) before the operation and at 3 months after. Laser prostatectomy was found to be the most costly and least effective way of treating BPH. This conclusion was valid both in terms of cost per prostate symptom score and cost per improvement of quality of life index. This study shows how a rough estimate can be made of the potential burdens that alternative treatment methods would impose on a country's health budget.

Entities:  

Mesh:

Year:  2005        PMID: 16180484     DOI: 10.1007/s10916-005-6105-5

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  8 in total

Review 1.  BPH and sexuality.

Authors:  A R Zlotta; C C Schulman
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

2.  Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of costs.

Authors:  P Blomqvist; A Ekbom; P Carlsson; C Ahlstrand; J E Johansson
Journal:  Urology       Date:  1997-08       Impact factor: 2.649

3.  Economic burden of treated benign prostatic hyperplasia in the United Kingdom.

Authors:  M F Drummond; A J McGuire; N A Black; M Petticrew; C K McPherson
Journal:  Br J Urol       Date:  1993-03

4.  High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup.

Authors:  F C D'Ancona; E A Francisca; W P Witjes; L Welling; F M Debruyne; J J de la Rosette
Journal:  J Urol       Date:  1997-07       Impact factor: 7.450

Review 5.  Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.

Authors:  L M Eri; K J Tveter
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 6.  The economics of benign prostatic hyperplasia treatment: a literature review.

Authors:  M A Kortt; J L Bootman
Journal:  Clin Ther       Date:  1996 Nov-Dec       Impact factor: 3.393

7.  The Oxford Laser Prostate Trial: economic issues surrounding contact laser prostatectomy.

Authors:  S R Keoghane; K C Lawrence; A M Gray; D B Chappel; A M Hancock; D W Cranston
Journal:  Br J Urol       Date:  1996-03

8.  Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.

Authors:  F C Lowe; R L McDaniel; J J Chmiel; A L Hillman
Journal:  Urology       Date:  1995-10       Impact factor: 2.649

  8 in total
  2 in total

1.  The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States.

Authors:  David A Taub; John T Wei
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

2.  Best laser for prostatectomy in the year 2013.

Authors:  Pankaj N Maheshwari; Nitin Joshi; Reeta P Maheshwari
Journal:  Indian J Urol       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.